DR. MICHAEL P. FARRELL M.D., PH.D.
NPI 1841396959
Internal Medicine - Hematology & Oncology in Middletown, CT

Active since September 15, 2006PECOS EnrolledAccepts Medicare Assignment
100/100
CMS Quality Rating
536 SAYBROOK RD, MIDDLETOWN, CT 06457(860) 358-2220(860) 358-2222 Get Directions Write a Review

NPPES record last updated: July 8, 2007. Verified against the NPPES registry weekly; last sync: August 16, 2026.

About Dr. Michael P. Farrell M.d., Ph.d. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. MICHAEL P. FARRELL M.D., PH.D. (NPI 1841396959) is an individual hematology & oncology provider in Middletown, Connecticut, licensed in Connecticut (038884) and active in the NPI registry since September 2006. He is enrolled in Medicare PECOS and is a graduate of Other (1997).

NPPES Registry Identity

NPI1841396959
Entity TypeIndividualMale
Primary Taxonomy207RH0003X
Provider Legal NameDR. MICHAEL P. FARRELLCredential: M.D., PH.D.
Location Address536 SAYBROOK RDMiddletown, CT 06457-4712
Mailing Address536 Saybrook RdMiddletown, CT 06457-4712 · (860) 358-2220 · Fax (860) 358-2222
Fax(860) 358-2222
Sole ProprietorNo
Medical School CMSOtherGraduated 1997
Enumeration DateSeptember 15, 2006
Last NPPES UpdateJuly 8, 2007
NPI 1841396959 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyInternal Medicine · Hematology & OncologyAllopathic & Osteopathic Physicians
Taxonomy Code207RH0003X
License Licensed in CT · 038884
Definition
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
536 SAYBROOK RD, Middletown, CT 06457

Other Identifiers 11

OtherP00070721CT · Railroad Medicare
Other010038884CT01CT · Anthem
Other784860CT · Connecticare
Other038884United Healthcare
Medicare ID-Type Unspecified830000124CT
Other2V3309CT · Healthnet
OtherP3010513Oxford
Medicare UPINH80574CT
Medicaid001388843CT
Other7788478Aetna
Other010038884CT01CT · Bluecare Family Plan

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Michael P. Farrell M.d., Ph.d. is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID7618001934
PECOS Enrollment IDI20100823000013
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 26

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram Q5101
Filgrastim-sndz, also known as Zarxio, is a biosimilar medicine administered via injection. It's designed to stimulate the growth of white blood cells, which play a crucial role in your body's defense against infections. This can be particularly beneficial if your white blood cell count is low due to certain treatments or conditions.
110,763 services18 patients
Injection, ferric carboxymaltose, 1 mg J1439
Ferric carboxymaltose is an iron supplement injection. It's given when your body needs more iron than you can consume through diet, like in anemia. The injection is administered by a healthcare professional into a vein.
18,750 services15 patients
Injection, fosaprepitant, 1 mg J1453
Fosaprepitant is an anti-nausea medication given via injection. It's often used to prevent nausea and vomiting caused by chemotherapy. This injection blocks signals to the brain that trigger these symptoms, helping you feel better.
16,200 services25 patients
Injection, epoetin alfa, (for non-esrd use), 1000 units J0885
Epoetin alfa is a medication injected to help your body produce more red blood cells, improving energy levels and reducing tiredness. It's often used for patients with certain types of anemia. Each injection contains 1000 units of the medicine.
8,480 services15 patients
Injection, dexamethasone sodium phosphate, 1 mg J1100
Dexamethasone sodium phosphate is a medication given via injection. It is a type of steroid that helps reduce inflammation and immune responses. It can be used to treat a variety of conditions, such as allergies, skin conditions, arthritis, and more.
1,949 services33 patients
Injection, palonosetron hcl, 25 mcg J2469
Palonosetron HCL is an injection used to prevent nausea and vomiting caused by chemotherapy. It works by blocking a natural substance (serotonin) in the body that can cause vomiting. This helps improve your comfort during cancer treatment.
1,060 services26 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 06457 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$183.10 typical visit price
range $60.82 – $183.10
Typical copayment $45.77 (range $15.20 – $45.77)
Most-billed visit code 99205
Established Patient
$106.68 typical visit price
range $19.76 – $149.26
Typical copayment $26.67 (range $4.94 – $37.31)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

100/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice
Quality94.31
Promoting Interoperability100
Improvement Activities40

Reported Quality Measures

Advance Care Plan
4%582 patients1/55-star benchmark: 100%
Closing the Referral Loop: Receipt of Specialist Report
0%126 patients1/55-star benchmark: 87%
Controlling High Blood Pressure
62%42 patients3/55-star benchmark: 91%
Documentation of Current Medications in the Medical Record
88%2,988 patients4/55-star benchmark: 100%
Oncology: Advance Care Planning in Metastatic Cancer Patients
0%73 patients1/55-star benchmark: 85%
Oncology: Medical and Radiation - Pain Intensity Quantified
96%806 patients4/55-star benchmark: 100%
Oncology: Medical and Radiation - Plan of Care for Pain
0%54 patients1/55-star benchmark: 100%
Oncology: Patient-Reported Pain Improvement
38%45 patients
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
26%899 patients2/55-star benchmark: 98%
Preventive Care and Screening: Screening for Depression and Follow-Up Plan
0%896 patients1/55-star benchmark: 97%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Patients screened: 19% · 406 patients
17%406 patients
Provide Patients Electronic Access to Their Health Information
88%440 patients4/55-star benchmark: 100%
Use of High-Risk Medications in Older Adults
Lower rates are better for this measure.
5%612 patients4/55-star benchmark: 100%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 20

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Internal Medicine (Hematology & Oncology)
536 SAYBROOK RD
MIDDLETOWN, CT 06457
Pharmacist (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist)
536 SAYBROOK RD
MIDDLETOWN, CT 06457
Pharmacy (Specialty Pharmacy)
536 SAYBROOK RD, LOWER LEVEL
MIDDLETOWN, CT 06457
Internal Medicine (Hematology & Oncology)
536 SAYBROOK RD
MIDDLETOWN, CT 06457
Internal Medicine (Medical Oncology)
536 SAYBROOK RD
MIDDLETOWN, CT 06457
Pharmacist (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist)
536 SAYBROOK RD
MIDDLETOWN, CT 06457
Radiology (Therapeutic Radiology)
536 SAYBROOK RD
MIDDLETOWN, CT 06457
Nurse Practitioner (Family)
536 SAYBROOK RD
MIDDLETOWN, CT 06457

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Michael Farrell's NPI number?

The NPI number for Michael Farrell is 1841396959. It was assigned to this individual provider in the NPPES registry on September 15, 2006.

Where is Michael Farrell located?

Michael Farrell practices at 536 Saybrook Rd, Middletown, CT 06457. The listed phone number is (860) 358-2220.

What is Michael Farrell's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Hematology & Oncology, with taxonomy code 207RH0003X.

Is Michael Farrell enrolled in Medicare?

Yes. Michael Farrell is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

When was this NPI record last updated?

The NPPES record for Michael Farrell was last updated on July 8, 2007. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 19 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.